Nitrolingual
Nitrolingual is a medicine authorised by Swissmedic under authorisation number 40558. The authorisation holder is Gebro Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 November 1977 and the authorisation is valid without a time limit. ATC code C01DA02 places the medicine in the group Cardiac therapy.
| Authorisation number | 40558 |
|---|---|
| Name | Nitrolingual |
| Full name | Nitrolingual, Sublingualspray |
| Authorisation holder | Gebro Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C01DA02 |
| First authorisation | 28 November 1977 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Nitrolingual, Sublingualspray | B | 30 December 1996 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 200 | Einzeldose(n) | C01DA02 | 02.04.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Nitrolingual authorised in Switzerland?
Yes. Nitrolingual is authorised by Swissmedic under authorisation number 40558, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Nitrolingual have?
Nitrolingual is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Nitrolingual?
The authorisation holder is Gebro Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.